成人毛细胞型星形细胞瘤患者的管理与生存:基于美国国家癌症数据库的分析
本研究纳入美国国家癌症数据库2004年至2014年诊断的3057例成人中枢神经系统毛细胞型星形细胞瘤患者,中位年龄32岁,分析临床管理与总生存的关系。多因素分析显示,年龄较大、收入较低、Charlson/Deyo评分较高、肿瘤较大及放疗技术(外照射放疗HR 3.37)与较差的总生存相关。
要点
- 3057例成人毛细胞型星形细胞瘤患者中,77%仅接受手术治疗,11.9%接受手术加放疗。
- 多因素分析中,年龄较大(HR 1.05)、收入较低、Charlson/Deyo评分较高、肿瘤较大及外照射放疗(HR 3.37)与较差总生存相关。
- 作者认为,对于不适合切除或放射外科治疗的患者,显然需要新的治疗方法。
核心结论
- 作者认为,本研究提供了当代成人毛细胞型星形细胞瘤患者的大规模预后信息,证实年龄、中位收入、Charlson/Deyo评分和肿瘤大小对总生存有显著影响。
- 作者指出,尽管切除状态、肿瘤大小和位置可能使外照射放疗存在偏倚,但对于不适合切除或放射外科治疗的患者,显然需要新的治疗方法。
研究设计与样本
- 研究为基于美国国家癌症数据库的队列分析,纳入2004年至2014年诊断、年龄大于18岁的中枢神经系统毛细胞型星形细胞瘤患者,共3057例,中位年龄32岁。
- 采用单因素和多因素分析评估临床与治疗相关特征与诊断后总生存的关联。
主要发现
- 诊断时,1138例(41%)为大脑肿瘤,832例(30%)为小脑肿瘤,252例(9%)为脊髓肿瘤,534例(19%)为未明确部位肿瘤。
- 超过四分之三(77%)的患者仅接受手术作为局部治疗,其余分别为手术加放疗(11.9%)、单纯放疗(4.5%)和单纯活检(6.9%)。
- 多因素分析中,与较差总生存相关的因素包括年龄较大(风险比[HR] 1.05;P < 0.001)、收入较低(P < 0.001)、Charlson/Deyo评分较高(P = 0.023)、肿瘤较大(P = 0.023)和放疗技术(P < 0.001;外照射放疗[EBRT]的HR为3.37)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adult pilocytic astrocytomas (PAs) are relatively rare central nervous system (CNS) tumors with a favorable prognosis. We sought to investigate existing clinical management strategies and overall survival (OS) as a function of various clinical characteristics in a cohort of adult patients with PA. METHODS: The study cohort comprised all patients age >18 years diagnosed with a CNS PA diagnosed between 2004 and 2014 and included in the National Cancer Database. Clinical and treatment-related characteristics were recorded and analyzed for associations with OS following diagnosis using univariate and multivariate analyses. RESULTS: A total of 3057 adult patients, with a median age of 32 years, met the inclusion criteria. At diagnosis, 1138 patients (41%) had cerebral tumors, 832 (30%) had cerebellar tumors, 252 (9%) had tumors of the spinal cord, and 534 (19%) had tumors of unspecified location. More than three-quarters (77%) of the patients underwent surgery alone as local therapy, with the remainder split among surgery plus radiation (11.9%), radiation alone (4.5%), and biopsy alone (6.9%). On multivariate analysis, factors associated with inferior OS included older age (hazard ratio [HR], 1.05; P < 0.001), lower income (P < 0.001), higher Charlson/Deyo score (P = 0.023), larger tumor size (P = 0.023), and radiation therapy technique (P < 0.001; HR, 3.37 for external beam radiation therapy [EBRT]). CONCLUSIONS: Our data provide large-scale prognostic information from a contemporary cohort of patients with PA, confirming that age, median income, Charlson/Deyo Score, and tumor size have significant effects on OS. Although resection status, tumor size, and location likely bias against EBRT, novel therapeutics are clearly needed in patients with tumors not amenable to resection or radiosurgery.
引用
- Lee KJ, Marchan E, Peterson J, et al. Management and Survival of Adult Patients with Pilocytic Astrocytoma in the National Cancer Database. World Neurosurg. 2018. PMID: 29427814. doi:10.1016/j.wneu.2018.01.208
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。